Clinical Trial Update: Phase III Study to Evaluate Morning Testosterone Normalization in Overweight Men With Secondary Hypogonadism [Phase 3]

View source ↗

Summary

Phase III study evaluating morning testosterone normalization in overweight men with secondary hypogonadism has completed, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism

Drugs mentioned

• TESTOSTERONE (testosterone)

Snippet

Sponsor: Repros Therapeutics Inc. | Conditions: Secondary Hypogonadism | Phase 3 | Status: COMPLETED | Results posted: 2015-05-27